*Eligible European countries: Germany, Belgium, Spain, Finland, France, Italy, Lithuania, Poland, Switzerland
"This support from the Roquette Foundation for Health is fundamental because this project represents a major potential breakthrough in the treatment of food allergies. A vaccine approach will make it possible to treat a larger number of patients in the long run. Therefore, we will be able to change the lives of these patients suffering from severe food allergies."
Laurent Reber, Head of the Atip-Avenir team Asthma, allergy and immunotherapy, Inserm - Physiopathology Center of Toulouse-Purpan